β‐catenin‐mediated immune evasion pathways operate in CIC4, the group with the poorest prognosis in melanoma 14, whereas in this study we found no evidence of CTNNB1 differential expression between CIC2 and CIC4, nor was their mutational burden significantly different. Here, CTNNB1 is linked to melanoma.